News Focus
News Focus
Replies to #46402 on Biotech Values
icon url

p3analyze

05/10/07 2:22 AM

#46403 RE: DewDiligence #46402

then you are wrong- the same arguments against approval exist, they will still stick it to DNDN, except maybe you will be part of the collateral damage too. Or maybe not, since you will profit from the short position.